NervGen Pharma prices public offering at $2.50 per share
NervGen Pharma has announced the pricing of a public offering of 24M common shares at $2.50 each.
The offering also includes warrants to purchase the same number of shares at an exercise price of $3.68.
The company’s decision to issue new shares and warrants may be seen as a strategic move to raise capital and expand its operations.